These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10966510)

  • 1. Evaluation of in vitro reporter gene induction assays for use in a rapid prescreen for compound selection to test specificity in the Tg.AC mouse short-term carcinogenicity assay.
    Thompson KL; Rosenzweig BA; Tsong Y; Sistare FD
    Toxicol Sci; 2000 Sep; 57(1):43-53. PubMed ID: 10966510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of drugs to test the specificity of the Tg.AC assay by screening for induction of the gadd153 promoter in vitro.
    Thompson KL; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):260-70. PubMed ID: 12730611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
    Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.
    Thompson KL; Rosenzweig BA; Sistare FD
    Toxicol Pathol; 1998; 26(4):548-55. PubMed ID: 9715514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.
    Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW
    Toxicol Sci; 1999 Jun; 49(2):241-54. PubMed ID: 10416269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogens.
    Holden HE; Stoll RE; Blanchard KT
    Toxicol Pathol; 1999; 27(5):507-12. PubMed ID: 10528629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
    Spalding JW; Momma J; Elwell MR; Tennant RW
    Carcinogenesis; 1993 Jul; 14(7):1335-41. PubMed ID: 8330346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.
    Honchel R; Rosenzweig BA; Thompson KL; Blanchard KT; Furst SM; Stoll RE; Sistare FD
    Mol Carcinog; 2001 Feb; 30(2):99-110. PubMed ID: 11241757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-protein interactions in the proximal zeta-globin promoter: identification of novel CCACCC- and CCAAT-binding proteins.
    Sabath DE; Koehler KM; Yang WQ; Phan V; Wilson J
    Blood Cells Mol Dis; 1998 Jun; 24(2):183-98. PubMed ID: 9642099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
    Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical analysis of skin tumor data from Tg.AC mouse bioassays.
    Dunson DB; Haseman JK; van Birgelen AP; Stasiewicz S; Tennant RW
    Toxicol Sci; 2000 Jun; 55(2):293-302. PubMed ID: 10828260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.
    Hansen LA; Trempus CS; Mahler JF; Tennant RW
    Carcinogenesis; 1996 Sep; 17(9):1825-33. PubMed ID: 8824502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tg rasH2 mouse in cancer hazard identification.
    Morton D; Alden CL; Roth AJ; Usui T
    Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model.
    Tennant RW; Stasiewicz S; Eastin WC; Mennear JH; Spalding JW
    Toxicol Pathol; 2001; 29 Suppl():51-9. PubMed ID: 11695562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of dimethylvinyl chloride increases frequency of forestomach papillomas in Tg.AC mice.
    Cannon RE; Graves S; Spalding JW; Trempus CS; Tennant RW
    Mol Carcinog; 2000 Dec; 29(4):229-35. PubMed ID: 11170261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-Ha-ras gene expression in liver and kidney of transgenic Tg.AC mice following chemically induced tissue injury.
    Delker DA; Yano BL; Gollapudi BB
    Toxicol Sci; 1999 Jul; 50(1):90-7. PubMed ID: 10445757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tripropylene glycol diacrylate but not ethyl acrylate induces skin tumors in a twenty-week short-term tumorigenesis study in Tg.AC (v-Ha-ras) mice.
    Nylander-French LA; French JE
    Toxicol Pathol; 1998; 26(4):476-83. PubMed ID: 9715506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.